Company: GIFLF
Filing Date: 2025-03-31
Form Type: 6-K
Source: 0001104659-25-029805
Chunk: 1

Company: Grifols SA
Filing Date: 2025-03-31
Form: 6-K
Chunk 1
---
 expiration of the deadline for accepting the delisting offer they will apply for the cancellation
of the admission of the shares of Biotest to trading on the Frankfurt Securities Exchange.

The terms and conditions of the delisting offer
will be communicated in the offer document ("Offer Document") to be prepared by Grifols and to be examined by the German
federal financial supervisory authority, the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) in the coming weeks.

Once the Offer Document is approved by BaFin,
it will be published in accordance with applicable laws and will also be reported as inside information, and its contents will be published
on Grifols' website.

In Barcelona, on 31 March 2025.

| Nuria Martín Barnés                 |
| Secretary to the Board of Directors |

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

| Grifols, S.A. |                   |                      |
| By:           | /s/ David I. Bell |                      |
|               | Name:             | David I. Bell        |
|               | Title:            | Authorized Signatory |

Date: March 31, 2025